Evaluation and Refinement of KF-STRIDE Into the Interview!

NCT ID: NCT07168941

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, we will partner with the autism community, using mixed methodology to ensure our modifications are performed with community-engaged methods. We will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. We will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, we propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kessler Foundation STRength IDentification and Expression (KF-STRIDE)

Group Type EXPERIMENTAL

KF-STRIDE

Intervention Type BEHAVIORAL

KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview

Services as Usual

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

KF-STRIDE

KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* You live in the United States of America
* You speak English Fluently and at a 4th grade reading level

Exclusion Criteria

* You have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
* You have a history of substance abuse
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kessler Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helen Genova

Associate Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kessler Foundation

East Hanover, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Helen Genova

Role: CONTACT

973-324-8390

Katarina Reduzzi

Role: CONTACT

973-323-3750

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katarina Reduzzi

Role: primary

973-323-3750

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-1238-23

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Motivation for Daily Living Skills
NCT07159308 RECRUITING NA